A hemolyzed specimen is a blood sample in which red blood cells have ruptured, spilling their contents into the surrounding fluid. That leakage contaminates the sample with substances normally locked inside those cells, and it can throw off the results of common lab tests. Hemolysis is the single most common reason clinical laboratories reject blood samples, and for patients it usually means a longer wait and a second blood draw.
What Actually Happens Inside a Hemolyzed Tube
Red blood cells are packed with potassium, hemoglobin, certain enzymes, and other molecules that they normally keep tucked away behind their membranes. When those membranes break open, everything inside floods into the serum or plasma that the lab was planning to analyze. The result is a sample that looks pink, red, or even dark cherry-colored instead of the normal straw-yellow of separated serum. That discoloration is free hemoglobin, and it acts as a visual warning sign that the sample’s chemistry has been scrambled.
The problem is not just cosmetic. Because the lab’s instruments measure what is dissolved in the liquid portion of the blood, the extra potassium, enzymes, and hemoglobin that leaked out of the broken cells get counted as though they were naturally circulating in the patient’s bloodstream. Some test values go up artificially, others go down, and a few stay unaffected. A doctor reading those results without knowing the sample was hemolyzed could make treatment decisions based on numbers that do not reflect what is really happening in the patient.
Which Lab Tests Get Distorted
Not every analyte is affected equally. A study evaluating interference on a widely used chemistry platform found that hemolysis pushed several values higher by more than ten percent. The biggest offenders were lactate dehydrogenase (LDH), aspartate aminotransferase (AST), folate, potassium, creatine kinase, and phosphorus. Meanwhile, haptoglobin, high-sensitivity troponin T, and alkaline phosphatase were falsely lowered by hemolysis.1PubMed. Hemolysis indexes for biochemical tests and immunoassays on Roche analyzers: determination of allowable interference limits according to different calculation methods
Potassium deserves special attention because even a small false elevation matters. Red blood cells contain far more potassium than the plasma around them, so a modest amount of hemolysis can push a potassium reading above the normal range, creating what looks like hyperkalemia on paper. Clinicians may then pursue unnecessary follow-up or treatment for a problem the patient does not actually have.2PubMed Central. Errors in potassium measurement: a laboratory perspective for the clinician The reverse scenario is equally dangerous: in whole blood point-of-care testing, unrecognized hemolysis can mask genuinely low potassium because the leaked potassium inflates the reading back into a normal-looking range.3The Journal of Applied Laboratory Medicine. Hemolysis Rates in Whole Blood Samples for Blood Gas/Electrolyte Analysis by Point-of-Care Testing
Coagulation tests are vulnerable too. Clotting assays like prothrombin time (PT) and activated partial thromboplastin time (aPTT) rely on optical detection methods that hemoglobin interferes with. Research has shown that once free hemoglobin in the plasma reaches roughly 1 to 1.5 grams per deciliter, these clotting results become unreliable.4PubMed Central. The effects of hemolysis on plasma prothrombin time and activated partial thromboplastin time tests using photo-optical method
In Vitro Versus In Vivo Hemolysis
Laboratories distinguish between two fundamentally different origins. In vitro hemolysis happens outside the body, during the blood draw itself or during sample handling, transport, or processing. In vivo hemolysis happens inside the patient’s body, driven by medical conditions such as autoimmune hemolytic anemia, sickle cell disease, transfusion reactions, or certain infections. The distinction matters because in vitro hemolysis means the sample is bad but the patient is fine, while in vivo hemolysis is a genuine clinical finding that the doctor needs to know about.5PubMed Central. Hemolyzed Specimens: Major Challenge for Identifying and Rejecting Specimens in Clinical Laboratories
Telling the two apart is not always straightforward. When a lab flags a sample as hemolyzed, the default assumption is usually that something went wrong during collection or handling. But if the hemolysis keeps showing up on repeated draws performed with careful technique, it raises the possibility that the patient’s red blood cells are actually breaking down in the circulation. Improving the ability to differentiate between these two causes is an active area of work in laboratory medicine, because getting it wrong in either direction has consequences: you either dismiss a real disease process or subject a sick patient to repeated unnecessary blood draws.6PubMed Central. Methods for Hemolysis Interference Study in Laboratory Medicine – A Critical Review
Why Blood Draws Cause Most Hemolysis
The vast majority of hemolyzed specimens trace back to the blood collection process itself. Red blood cells are fragile enough that shear forces, vacuum pressure, narrow-gauge needles, and turbulent flow can break them apart. The biggest single risk factor identified across multiple studies is drawing blood through an intravenous (IV) catheter rather than performing a fresh venipuncture with a straight needle.
One emergency department study found that samples drawn through IV catheters had a roughly 20 percent hemolysis rate, compared with less than one percent for samples drawn with a straight needle. When IV catheters were used with a vacuum tube rather than a syringe, the hemolysis rate climbed even higher, to around 22 percent.7Journal of Emergency Nursing. The effect of blood drawing techniques and equipment on the hemolysis of ED laboratory blood samples A systematic review and meta-analysis pooling data from multiple studies confirmed that hemolysis rates are consistently higher when blood is sampled from a peripheral IV line, though following a careful blood-sampling protocol through the IV can reduce the damage.8PubMed. Drawing blood from peripheral intravenous cannula compared with venepuncture: A systematic review and meta-analysis
Needle gauge plays a role as well. A more recent emergency department study found that drawing through a 20-gauge IV catheter with a Luer-Lock access device reduced hemolysis risk compared with smaller gauges. Difficult blood collections and male sex were also associated with higher hemolysis rates, though the reasons for the sex difference remain unclear.9Journal of Emergency Nursing. A Single-Center Prospective Study of the Effects of Different Methods of Phlebotomy in the Emergency Department on Blood Sample Hemolysis Rates
Earlier research comparing catheter draws to standard venipuncture tubes found a similar pattern: about 14 percent hemolysis when blood was drawn through a catheter versus roughly four percent with direct venipuncture, a statistically meaningful difference.10PubMed. A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining blood samples
What Happens After the Draw
Collection technique is not the only culprit. Once the tube leaves the patient’s arm, handling and transport can still break cells. Pneumatic tube systems, the vacuum-powered capsules hospitals use to shoot samples from a clinical unit down to the lab, are a well-documented risk. High transport speeds, sudden direction changes, and rapid acceleration or deceleration can all generate enough mechanical stress to lyse red blood cells.11PubMed Central. Hemolysis associated with pneumatic tube system transport for blood samples
Speed appears to be the key variable. Research comparing slow versus fast pneumatic tube settings found that at short distances with slow speeds, hemolysis was essentially absent, while high-speed transport over longer distances elevated hemolysis markers like LDH, potassium, and free hemoglobin. Hospitals can reduce this problem by validating their tube systems and, where possible, lowering the transport speed.12Clinical Chemistry and Laboratory Medicine. Speed of sample transportation by a pneumatic tube system can influence the degree of hemolysis
Centrifugation settings in the lab itself can also contribute, though research suggests that spinning samples at moderately higher speeds for shorter times generally does not harm most analytes. The exception is free hemoglobin measurement, which was affected by changes in centrifugation conditions.13PubMed Central. Influence of centrifugation conditions on the results of 77 routine clinical chemistry analytes using standard vacuum blood collection tubes and the new BD-Barricor tubes
How Labs Detect Hemolysis
Traditionally, a lab technician would look at the separated serum and judge whether it appeared pink or red. That eyeball method turns out to be surprisingly unreliable. A comparison of visual inspection versus automated detection found only moderate agreement between human observers and instruments, and the researchers concluded that visual inspection should be replaced by automated serum-index measurements.14Clinical Chemistry and Laboratory Medicine. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye?
Modern chemistry analyzers can measure a hemolysis index automatically on every sample. This index quantifies how much free hemoglobin is present in the serum, and the lab’s information system compares that number against thresholds set for each individual test. A study comparing visual assessment with hemolysis-index-based detection found meaningful discrepancies, particularly for potassium and phosphate, where the automated system flagged more samples for rejection than the human eye caught.15PubMed. Comparison of Visual Assessment and Hemolysis Index in Detecting Hemolysis across Common Biochemical Assay: Implications for Sample Rejection in Clinical Laboratory Practice
Whole blood samples, like those used in bedside blood gas analyzers, present a particular challenge because the cells have not been separated from the plasma. Without that separation step, there is no colored serum to inspect, and hemolysis can go undetected entirely. That is why point-of-care potassium readings in critically ill patients sometimes conflict with central lab values and need careful interpretation.3The Journal of Applied Laboratory Medicine. Hemolysis Rates in Whole Blood Samples for Blood Gas/Electrolyte Analysis by Point-of-Care Testing
How Labs Decide Whether to Report or Reject a Result
Not every hemolyzed sample is thrown out. Whether the lab reports the result, adds a warning comment, or cancels the test altogether depends on how much hemolysis was detected and which analyte is being measured. Labs set tiered thresholds: at low levels of interference, the result goes out with a note that hemolysis was present; at moderate levels, a comment is added warning the doctor that the value may be falsely high or low; and at high levels, the result is simply not released.16Annals of Laboratory Medicine. Impact of Individualized Hemolysis Management Based on Biological Variation Cut-offs in a Clinical Laboratory
Some labs use a one-size-fits-all rejection cutoff, canceling all results from any sample above a given hemolysis index. Others have moved to concentration-dependent thresholds, where the decision to report or reject is made analyte by analyte. If hemolysis exceeds the total allowable error for a given test, that specific result is suppressed, but other tests on the same sample may still be reportable.17The Journal of Applied Laboratory Medicine. Reducing Specimen Rejection Rates Using Concentration-Dependent Hemolysis Rejection Thresholds This more granular approach saves patients from unnecessary re-draws when only one analyte was truly affected.
The Cost of Hemolysis to Hospitals and Patients
When a sample is rejected, the patient has to wait for a new blood draw, the nurse or phlebotomist has to return for the stick, and the lab has to run the sample again. A study modeling the economic impact in a busy emergency department estimated that for a facility with 100,000 annual visits, a ten percent hemolysis rate, and a 40 percent draw rate for routine chemistries, the direct cost runs to about four million dollars a year. Much of that expense comes from the added length of stay: on average, a patient whose sample hemolyzed spent an extra hour in the emergency department compared with one whose sample was fine.18PubMed. The Hidden Cost of Hemolyzed Blood Samples in the Emergency Department
An extra hour may not sound dramatic, but in a high-volume ED it cascades. Boarding patients block beds, extend wait times for everyone, and delay treatment decisions that hinge on lab results. For the individual patient, it means an additional needle stick and more time in an already unpleasant environment.
What Hospitals Are Doing to Reduce Hemolysis
Emergency departments tend to have the highest hemolysis rates in a hospital because the pace is fast, blood is often drawn through freshly placed IVs, and technique varies widely between providers. Targeted quality-improvement programs have made a real dent. One tertiary hospital reduced its ED hemolysis rate from roughly 20 percent down to about five percent after implementing a bundle of changes: switching from vacuum tubes to syringes for IV-drawn samples, increasing the use of dedicated venipuncture instead of pulling blood from IV lines, increasing sample volumes, and shortening the time between collection and lab analysis.19PubMed. Reducing blood sample hemolysis at a tertiary hospital emergency department
The evidence behind these strategies is robust. A systematic review and meta-analysis of best practices found that drawing blood with a fresh straight needle instead of through an IV start reduced hemolysis by about 84 percent on average. When IV catheter draws were unavoidable, using the antecubital site (the inner elbow) rather than a hand or forearm vein cut hemolysis by about half.20PubMed Central. Effectiveness of practices to reduce blood sample hemolysis in EDs: A laboratory medicine best practices systematic review and meta-analysis These findings were rated as high-strength evidence and are now recommended as standard practice in emergency settings.
Hemolysis in Newborns
Neonates present a unique challenge. Their blood is often collected via heel sticks rather than venipuncture, and the tiny volumes involved increase the relative risk of hemolysis. Researchers have looked at whether birth weight, gestational age, or the timing of the draw influence hemolysis in heel-stick samples, and none of these factors showed a meaningful relationship. The hemolysis that occurred was largely related to the collection device and technique rather than the infant’s characteristics.21Archives of Pediatrics & Adolescent Medicine. Comparison of Hemolysis in Blood Samples Collected Using an Automatic Incision Device and a Manual Lance
One practice sometimes used before a heel stick is warming the foot to increase blood flow and reduce squeezing. A randomized controlled trial comparing three warming methods found that while they did produce different skin temperatures, none of them made a difference in the hemolysis index of the resulting blood sample, nor in the infant’s comfort scores.22PubMed Central. Warming Prior to Heel Stick Blood Sample Quality and Infant Comfort—A Randomized Controlled Trial So warming may still be worth doing for blood flow, but it should not be expected to reduce hemolysis specifically.
Hemolysis in Veterinary Medicine
Hemolysis is not only a human medicine problem. Veterinary diagnostic labs face the same issue, often magnified by the difficulty of collecting clean samples from animals. In cattle, a study that artificially induced increasing levels of hemolysis found that eight of the fourteen biochemical parameters tested were significantly affected. Calcium and total bilirubin became falsely low at moderate hemolysis, while albumin and cholesterol climbed at higher levels. The degree of hemolysis needed to produce clinically meaningful bias varied by analyte and by the analytical method used, making blanket rejection rules especially impractical in veterinary settings.23Research in Veterinary Science. Influence of haemolysis on blood biochemistry profiles in cattle
Some bovine-specific tests are more resilient than others. Non-esterified fatty acids (NEFAs), an important marker for metabolic health in dairy cows, are significantly inflated by hemolysis and can cross critical decision thresholds in moderately hemolyzed samples. Beta-hydroxybutyrate (BHB), by contrast, remains accurate even in visibly hemolyzed blood. For NEFA assays, including a sample blank in the measurement protocol prevents much of the interference, but veterinary labs and practitioners need to be aware that hemolyzed NEFA results cannot be trusted at face value.24PubMed. Effect of hemolysis on nonesterified fatty acid and beta-hydroxybutyrate concentrations in bovine blood
What to Do If Your Blood Sample Is Hemolyzed
If you have ever been told the lab needs to redraw your blood because the first sample was hemolyzed, it almost certainly was not your fault. It was a mechanical issue during the draw or afterward. You can ask that the second draw be done with a fresh needle stick rather than pulled from an existing IV line, which significantly reduces the odds of it happening again. If you are a difficult stick, let the phlebotomist know so they can take extra care with technique and choose an appropriate site.
If hemolysis keeps happening across multiple draws performed by different people with good technique, mention it to your doctor. Repeated hemolysis in carefully collected samples can sometimes be the first clue to an underlying condition that is destroying red blood cells in the circulation. It is uncommon, but worth flagging if the pattern persists. In most cases, though, a hemolyzed specimen is a short-lived inconvenience that resolves with a single additional blood draw.